Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Long-Term Investments (2016 - 2018)

Historic Long-Term Investments for Utah Medical Products (UTMD) over the last 7 years, with Q1 2018 value amounting to $72000.0.

  • Utah Medical Products' Long-Term Investments rose 1250.0% to $72000.0 in Q1 2018 from the same period last year, while for Mar 2018 it was $72000.0, marking a year-over-year increase of 1250.0%. This contributed to the annual value of $80000.0 for FY2017, which is 2500.0% up from last year.
  • Per Utah Medical Products' latest filing, its Long-Term Investments stood at $72000.0 for Q1 2018, which was up 1250.0% from $80000.0 recorded in Q4 2017.
  • In the past 5 years, Utah Medical Products' Long-Term Investments ranged from a high of $80000.0 in Q4 2017 and a low of $44000.0 during Q1 2016
  • Over the past 5 years, Utah Medical Products' median Long-Term Investments value was $56000.0 (recorded in 2014), while the average stood at $59294.1.
  • Its Long-Term Investments has fluctuated over the past 5 years, first tumbled by 2372.88% in 2016, then skyrocketed by 6000.0% in 2017.
  • Quarter analysis of 5 years shows Utah Medical Products' Long-Term Investments stood at $58000.0 in 2014, then dropped by 5.17% to $55000.0 in 2015, then increased by 16.36% to $64000.0 in 2016, then rose by 25.0% to $80000.0 in 2017, then decreased by 10.0% to $72000.0 in 2018.
  • Its Long-Term Investments was $72000.0 in Q1 2018, compared to $80000.0 in Q4 2017 and $78000.0 in Q3 2017.